Prognostic Factors of Peritoneal Metastases from Colorectal Cancer following Cytoreductive Surgery and Perioperative Chemotherapy

<table>Survival curves of patients with PCI ≤ 10 and those with PCI ≥ 11. MST and 5-year survival rate in patients with PCI ≤ 10 were 33.7 months and 40.0%, but those in patients with PCI ≥ 11 were 10.5 months and 2.9%, respectively.</table>

The Scientific World Journal

fig4

Figure 4

Figure 4: Prognostic Factors of Peritoneal Metastases from Colorectal Cancer following Cytoreductive Surgery and Perioperative Chemotherapy 